37 related articles for article (PubMed ID: 28347547)
1. Correction to: Theranostic role of
Yang Q; Chen Z; Qiu Y; Huang W; Wang T; Song L; Sun X; Li C; Xu X; Kang L
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1495. PubMed ID: 38212532
[No Abstract] [Full Text] [Related]
2. Rational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3.
Dianati V; Shamloo A; Kwiatkowska A; Desjardins R; Soldera A; Day R; Dory YL
ChemMedChem; 2017 Aug; 12(15):1169-1172. PubMed ID: 28722823
[TBL] [Abstract][Full Text] [Related]
3. The proprotein convertase furin in tumour progression.
Jaaks P; Bernasconi M
Int J Cancer; 2017 Aug; 141(4):654-663. PubMed ID: 28369813
[TBL] [Abstract][Full Text] [Related]
4. Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease.
Wu Q; Chen S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362216
[TBL] [Abstract][Full Text] [Related]
5. Testicular Germ Cell Tumours and Proprotein Convertases.
Velado-Eguskiza A; Gomez-Santos L; Badiola I; Sáez FJ; Alonso E
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406405
[TBL] [Abstract][Full Text] [Related]
6. The effects and possible mechanism of action of apolipoprotein M on the growth of breast cancer cells.
Zhou Y; Yao S; Yu M; Wei J; Fang Q; Xu N; Luo G
Mol Biol Rep; 2022 Feb; 49(2):1171-1179. PubMed ID: 34775573
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of microRNA-135 or silencing of PCSK6 attenuates inflammatory response in preeclampsia by restricting NLRP3 inflammasome.
Zhao X; Zhang X; Wu Z; Mei J; Li L; Wang Y
Mol Med; 2021 Jul; 27(1):82. PubMed ID: 34301174
[TBL] [Abstract][Full Text] [Related]
8. PACE4 Expression is a Novel Independent Prognostic Factor in Nasopharyngeal Carcinoma.
Lin Y; Long H; Tan X; Zhang D; Jiang L
Cancer Manag Res; 2020; 12():8623-8629. PubMed ID: 32982453
[TBL] [Abstract][Full Text] [Related]
9. Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human Melanoma.
Weishaupt C; Mastrofrancesco A; Metze D; Kemper B; Stegemann A; Picardo M; Klein-Szanto AJP; Böhm M
Acta Derm Venereol; 2020 May; 100(10):adv00157. PubMed ID: 32449780
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
Okada K; Moon HJ; Finney J; Meier A; Mure M
Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of PACE4 isoforms as biomarkers in thyroid cancer.
Fradet L; Temmar R; Couture F; Belzile M; Fortier PH; Day R
J Otolaryngol Head Neck Surg; 2018 Oct; 47(1):63. PubMed ID: 30340539
[TBL] [Abstract][Full Text] [Related]
12. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Bassi DE; Mahloogi H; Klein-Szanto AJ
Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
[TBL] [Abstract][Full Text] [Related]
13. PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.
Couture F; Levesque C; Dumulon-Perreault V; Ait-Mohand S; D'Anjou F; Day R; Guérin B
Neoplasia; 2014 Aug; 16(8):634-43. PubMed ID: 25220591
[TBL] [Abstract][Full Text] [Related]
14. Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue.
Dianati V; Navals P; Couture F; Desjardins R; Dame A; Kwiatkowska A; Day R; Dory YL
J Med Chem; 2018 Dec; 61(24):11250-11260. PubMed ID: 30501188
[TBL] [Abstract][Full Text] [Related]
15. Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Bassi DE; Fu J; Lopez de Cicco R; Klein-Szanto AJ
Mol Carcinog; 2005 Nov; 44(3):151-61. PubMed ID: 16167351
[TBL] [Abstract][Full Text] [Related]
16. PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression.
Panet F; Couture F; Kwiatkowska A; Desjardins R; Guérin B; Day R
Eur J Cell Biol; 2017 Aug; 96(5):469-475. PubMed ID: 28347547
[TBL] [Abstract][Full Text] [Related]
17. Role of proprotein convertases in prostate cancer progression.
Couture F; D'Anjou F; Desjardins R; Boudreau F; Day R
Neoplasia; 2012 Nov; 14(11):1032-42. PubMed ID: 23226097
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
